Cargando…
The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy
Background: To identify the role of combination biopsy, which consists of both targeted and additional systematic cores, in the diagnosis of clinically significant prostate cancer (csPCa). Methods: We retrospectively reviewed patients with PSA levels 2.5–15 ng/mL who have a suspicious prostate lesio...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584506/ https://www.ncbi.nlm.nih.gov/pubmed/34768322 http://dx.doi.org/10.3390/jcm10214804 |
_version_ | 1784597465938264064 |
---|---|
author | Lee, Chung Un Choi, Joongwon Sung, Si Hyun Chung, Jae Hoon Song, Wan Kang, Minyong Sung, Hyun Hwan Jeong, Byong Chang Seo, Seong Il Jeon, Seong Soo Lee, Hyun Moo Jeon, Hwang Gyun |
author_facet | Lee, Chung Un Choi, Joongwon Sung, Si Hyun Chung, Jae Hoon Song, Wan Kang, Minyong Sung, Hyun Hwan Jeong, Byong Chang Seo, Seong Il Jeon, Seong Soo Lee, Hyun Moo Jeon, Hwang Gyun |
author_sort | Lee, Chung Un |
collection | PubMed |
description | Background: To identify the role of combination biopsy, which consists of both targeted and additional systematic cores, in the diagnosis of clinically significant prostate cancer (csPCa). Methods: We retrospectively reviewed patients with PSA levels 2.5–15 ng/mL who have a suspicious prostate lesion (with the Prostate Imaging Reporting and Data System (PI-RADS) ≥ 3) on multiparametric MRI (mpMRI) between January 2016 and December 2018. We analyzed biopsy results by PI-RADS score and biopsy methods (systematic, targeted, and combination biopsy). Results: Of the 711 total patients, an average of 4.0 ± 1.8 targeted and 8.6 ± 3.1 additional systematic biopsies were performed. The additional systematic biopsies were sampled outside the targeted biopsy area. The combination biopsies detected more csPCa (201 patients, 28.3%) than did the targeted (175 patients, 24.6%) or systematic (124 patients, 17.4%) biopsies alone (p < 0.001). In the initial biopsy samples, there was a 7% increase in the detection of csPCa than in targeted biopsy (62% to 69%). It increased by 11% in repeat biopsy (46% to 57%). There was no statistical significance in both groups (p = 0.3174). Conclusions: Combination biopsy has the benefit of detecting csPCa in both initial and repeat biopsy when there is a suspicious lesion on mpMRI. |
format | Online Article Text |
id | pubmed-8584506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85845062021-11-12 The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy Lee, Chung Un Choi, Joongwon Sung, Si Hyun Chung, Jae Hoon Song, Wan Kang, Minyong Sung, Hyun Hwan Jeong, Byong Chang Seo, Seong Il Jeon, Seong Soo Lee, Hyun Moo Jeon, Hwang Gyun J Clin Med Article Background: To identify the role of combination biopsy, which consists of both targeted and additional systematic cores, in the diagnosis of clinically significant prostate cancer (csPCa). Methods: We retrospectively reviewed patients with PSA levels 2.5–15 ng/mL who have a suspicious prostate lesion (with the Prostate Imaging Reporting and Data System (PI-RADS) ≥ 3) on multiparametric MRI (mpMRI) between January 2016 and December 2018. We analyzed biopsy results by PI-RADS score and biopsy methods (systematic, targeted, and combination biopsy). Results: Of the 711 total patients, an average of 4.0 ± 1.8 targeted and 8.6 ± 3.1 additional systematic biopsies were performed. The additional systematic biopsies were sampled outside the targeted biopsy area. The combination biopsies detected more csPCa (201 patients, 28.3%) than did the targeted (175 patients, 24.6%) or systematic (124 patients, 17.4%) biopsies alone (p < 0.001). In the initial biopsy samples, there was a 7% increase in the detection of csPCa than in targeted biopsy (62% to 69%). It increased by 11% in repeat biopsy (46% to 57%). There was no statistical significance in both groups (p = 0.3174). Conclusions: Combination biopsy has the benefit of detecting csPCa in both initial and repeat biopsy when there is a suspicious lesion on mpMRI. MDPI 2021-10-20 /pmc/articles/PMC8584506/ /pubmed/34768322 http://dx.doi.org/10.3390/jcm10214804 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lee, Chung Un Choi, Joongwon Sung, Si Hyun Chung, Jae Hoon Song, Wan Kang, Minyong Sung, Hyun Hwan Jeong, Byong Chang Seo, Seong Il Jeon, Seong Soo Lee, Hyun Moo Jeon, Hwang Gyun The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy |
title | The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy |
title_full | The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy |
title_fullStr | The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy |
title_full_unstemmed | The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy |
title_short | The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy |
title_sort | role of prostate combination biopsy consisting of targeted and additional systematic biopsy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584506/ https://www.ncbi.nlm.nih.gov/pubmed/34768322 http://dx.doi.org/10.3390/jcm10214804 |
work_keys_str_mv | AT leechungun theroleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT choijoongwon theroleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT sungsihyun theroleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT chungjaehoon theroleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT songwan theroleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT kangminyong theroleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT sunghyunhwan theroleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT jeongbyongchang theroleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT seoseongil theroleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT jeonseongsoo theroleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT leehyunmoo theroleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT jeonhwanggyun theroleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT leechungun roleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT choijoongwon roleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT sungsihyun roleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT chungjaehoon roleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT songwan roleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT kangminyong roleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT sunghyunhwan roleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT jeongbyongchang roleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT seoseongil roleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT jeonseongsoo roleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT leehyunmoo roleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy AT jeonhwanggyun roleofprostatecombinationbiopsyconsistingoftargetedandadditionalsystematicbiopsy |